HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts.

Abstract
While much is known about the beneficial effects of myocardial stress adaptation, relatively less information is available about the adaptive mechanisms. To explore the signaling pathways of stress adaptation, isolated working rat hearts were divided into three groups. Group I was adapted to stress by conventional technique of repeated ischemia and reperfusion consisting of 5 min of ischemia followed by 10 min of reperfusion, repeated four times. Group II was treated with 100 microM of genistein, a tyrosine kinase inhibitor, followed by preconditioning as described for group I. The third group, perfused with buffer only for 60 min, served as control. All hearts were subjected to 30 min of ischemia followed by 30 min of reperfusion. The results of our study demonstrated better postischemic myocardial functions in the preconditioned hearts as evidenced by increased aortic flow, coronary flow, developed pressure and lesser amount of tissue injury as evidenced by the decreased creatine kinase release. The preconditioning effects were associated with enhancement of phospholipase D activity in the heart. The preconditioning effect was almost abolished by the genistein treatment which also prevented the enhancement of phospholipase D activities. Additionally, preconditioning of the rat hearts stimulated protein kinase C, MAP kinase, and MAPKAP kinase 2 activities which were inhibited by genistein. The results identifies for the first time tyrosine kinase-phospholipase D as potential signaling pathway for ischemic preconditioning, and implicates the involvement of multiple protein kinases in myocardial adaptation to ischemia.
AuthorsN Maulik, M Watanabe, Y L Zu, C K Huang, G A Cordis, J A Schley, D K Das
JournalFEBS letters (FEBS Lett) Vol. 396 Issue 2-3 Pg. 233-7 (Nov 04 1996) ISSN: 0014-5793 [Print] England
PMID8914993 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Enzyme Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • Isoflavones
  • Genistein
  • MAP-kinase-activated kinase 2
  • Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • Protein Kinase C
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Phospholipase D
Topics
  • Animals
  • Calcium-Calmodulin-Dependent Protein Kinases (metabolism)
  • Enzyme Activation
  • Enzyme Inhibitors (pharmacology)
  • Genistein
  • Heart Rate (drug effects)
  • In Vitro Techniques
  • Intracellular Signaling Peptides and Proteins
  • Ischemic Preconditioning, Myocardial
  • Isoflavones (pharmacology)
  • Male
  • Myocardium (enzymology)
  • Phospholipase D (antagonists & inhibitors, metabolism)
  • Phosphorylation
  • Protein Kinase C (antagonists & inhibitors, metabolism)
  • Protein Serine-Threonine Kinases (metabolism)
  • Protein-Tyrosine Kinases (antagonists & inhibitors, metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Ventricular Function, Left (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: